Issues and Controversies Surrounding Qualitative Strategies For Identifying and Forecasting Cancer Causing Agents in the Human Environment

Pharmacology & Toxicology

Volumn 72, Issue , 1993, Pages 12-27

  Huff, James ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; DIETHYLSTILBESTROL; ENVIRONMENTAL CHEMICAL; MELPHALAN; METHOXSALEN; PHENACETIN;

ANIMAL EXPERIMENT; CANCER; CARCINOGEN TESTING; CHEMICAL CARCINOGENESIS; CONFERENCE PAPER; ENVIRONMENT; FORECASTING; HUMAN; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; PUBLIC HEALTH; RISK ASSESSMENT; STRUCTURE ACTIVITY RELATION;

ANIMAL; CARCINOGENICITY TESTS; CARCINOGENS, ENVIRONMENTAL; HUMAN; NEOPLASMS;

EID: 0027523432     PISSN: 09019928     EISSN: 16000773     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1993.tb01664.x     Document Type: Article

References (127)

1. Chemical carcinogenesis: too many rodent carcinogens
2. Too many carcinogens: mitogenesis increases mutagenesis
3. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP
4. Cellular and molecular mechanisms of chemically induced renal carcinogenesis
5. Molecular carcinogenesis in humans and rodents
6. The cell cycle: myths and realities
7. Methyl isocyanate: A review of health effects research since Bhopal
8. The rodent cancer test: An assay under siege
9. An overview of prechronic and chronic toxicity/carcinogenicity experimental study designs and criteria used by the National Toxicology Program
10. Comparative carcinogenicity of ethylene thiourea with or without perinatal exposure in rats and mice
11. Cell proliferation in carcinogenesis
12. Carcinogens
13. The presence of a 2μ‐globulin is necessary for d‐limonene promotion of male rat kidney tumors
14. Occupational cancer: Problems in interpreting human evidence
15. Exposure to dioxins as a risk factor for soft tissue sarcoma: A population‐based case‐control study
16. The sequential development of cancer: a morphological perspective
17. Cancer mortality in workers exposed to 2,3,7,8‐tetrachlorodibenzop‐dioxin
18. The evaluation of S phase hepatocytes in female B6C3F1 mice exposed to dichloromethane
19. Inhalation exposure to a hepatocarcinogenic concentration of dichloromethane does not induce sustained replicative DNA synthesis in hepatocytes of female B6C3F1 mice
20. Predictive strategies for selecting 379 NCI/NTP chemicals evaluated for carcinogenic potential: Scientific and public health impact
21. Retrospective evaluation of the NCI/NTP nomination and selection processes of 382 chemicals studied for long‐term carcinogenicity. AACR Abstract no. 693
22. Carcinogenicity and toxicity of four cadmium compounds inhaled by rats
23. Rodent carcinogens: Setting priorities
24. A re‐examination of false‐positive rates for carcinogenicity studies
25. Neoplasms observed in untreated and corn oil gavage control groups of F344N rats and (C57BL/6N x C3H/HeN)F1 (B6C3F1) mice
26. Comparison of site‐specific and overall tumor incidence analyses for 81 recent National Toxicology Program carcinogenicity studies
27. Use of dual control groups to estimate false positive rates in laboratory animal carcinogenicity studies
28. Do cage effects influence tumor incidence? An examination of laboratory animal carcinogenicity studies utilizing Fischer 344 rats
29. Lack of cage effects on liver tumor incidence in B6C3F1 mice
30. Carcinogenicity results for 114 laboratory animal studies used to assess for predictivity of four in vitro genetic toxicity assays for rodent carcinogenicity
31. Tumor incidence in Fischer 344 rats: NTP histological data
32. Species correlation in long‐term carcinogenicity studies
33. Arguments that discredit animal studies lack scientific support
34. Effects of corn oil, time‐related changes, and inter‐laboratory variability in tumor occurrence in control Fischer 344 (F344/N) rats
35. An examination of the association between maximum tolerated dose and carcinogenicity in 326 long term studies in rats and mice
36. Unrecognized renal cell carcinoma: pathological and diagnostic aspects
37. The impact of toxicity on carcinogenicity studies: implications for risk assessment
38. Ultrastructure of renal adenoma
39. Absence of morphologic correlation between chemical toxicity and chemical carcinogenesis
40. Chemicals and cancer in humans: First evidence in experimental animals
41. Carcinogenesis studies: Results from 398 experiments on 104 chemicals from the U.S. National Toxicology Program
42. Occurrence and relevance of chemically induced benign neoplasms in long‐term carcinogenicity studies
43. Chemicals associated with site‐specific neoplasia in 1394 long‐term carcinogenesis experiments in laboratory rodents
44. Scientific concepts, value, and significance of chemical carcinogenesis studies
45. Long‐term carcinogenesis studies on 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin & hexachlorodibenzo‐p‐dioxins
46. A historical perspective of the classification developed and used for chemical carcinogens by the National Toxicology Program: 1983‐1992
47. Chemical toxicity & chemical carcinogenesis. Is there a causal connection? Comparative morphological evaluation of 1500 experiments
48. Design strategies, results, and evaluations of long‐term chemical carcinogenesis studies
49. Applicability to humans of rodent‐specific sites of chemical carcinogenicity: tumors of the forestomach and of the harderian, preputial, and zymbal glands induced by benzene
50. 2,3,7,8‐TCDD: A potent & complete carcinogen in experimental animals
51. Identification of environmental agents likely to cause cancer in humans
52. Exposure to certain pesticides may pose real carcinogenic risk
53. Long‐term chemical carcinogenesis experiments for identifying potential human cancer hazards. Collective data base of the National Cancer Institute & National Toxicology Program (1976‐1991)
54. Perspective and overview of the concepts and value of hazard identification as the initial phase of the risk assessement for cancer and human health
55. Relevance to humans of carcinogenesis results from laboratory animal toxicology studies, 433‐‐440 & 453‐‐457
56. State of the science on the carcinogenicity of gasoline with particular reference to recent cohort mortality study results
57. Preamble
58. Prevention delayed is prevention denied
59. Angiosarcoma of the liver in workers exposed to vinyl chloride. First of two cases found in Italy
60. Vinyl chloride carcinogenesis: current results and perspectives
61. Cancer mortality in workers in chemical plant contaminated with dioxin
62. Liver lesions in B6C3F1 mive: The National Toxicology Program experience and position
63. Guidelines for combining neoplasms for evaluation of rodent carcinogenesis studies
64. The maximum tolerated dose: the debate
65. An alternative hypothesis on the role of chemically induced protein droplet (α2μ‐globulin) nephropathy in renal carcinogenesis
66. Does chemically induced hepatocyte proliferation predict liver carcinogenesis
67. Chemicals and human cancer: 1,3‐butadiene
68. Liver carcinogenesis is not a predicted outcome of chemically induced hepatocyte proliferation
69. Chemicals and human cancer
70. 1,3‐Butadiene: toxicity and carcinogenicity in laboratory animals and in humans
71. Inhalation toxicology and carcinogenesis studies of methylene chloride (dichloromethane) in F344/N rats and B6C3F1 mice
72. Accuracy of death certificates: a population‐based, complete coverage, one‐year autopsy study in East Germany
73. Overhauling carcinogen classification
74. Asbestos: scientific developements and implications for public policy
75. Occupational exposure to cadmium: final rule
76. Renal cell cancer and occupational to chemical agents
77. Comment on the significance of positive carcinogenicity studies using gavage as the route of exposure
78. Concordance of carcinogenic response between rodent species: potency dependand potential underestimation
79. Ligand/receptor binding for 2,3,7,8‐TCDD: implications for risk assessment
80. Increased cell division as a cause of human cancer
81. Alternatives to using human experience in assessing health risks
82. Dioxin risks revisited
83. EPA moves to reassess the risk of dioxin
84. More pieces in the dioxin puzzle
85. Cancer mortality in workers exposed to chlorophenoxy herbicides and chlorophenols
86. Initiation and promotion ‐ useful concepts for risk assessment?
87. Associations between several sites of cancer and twelve petroleum‐based liquids. Results from a case‐referent study in Montreal
88. The autopsy and cancer
89. Natural history of body weight gain, survival, and neoplasia in the F344 rat
90. Current trends in diagnosis and treatment of renal, upper urinary tract, and bladder carcinomas
91. The role of autopsy in cancer registration in Sweden, with particular reference to findings in Malmø
92. The origin of point mutations in human tumor cells
93. Carcinogenicity of cadmium aerosols in Wistar rats
94. Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays
95. Evidence that toxic injury is not always associated with induction of chemical carcinogenesis
96. The predictive value of rodent carcinogenicity tests in the evaluation of human risks
97. Human carcinogens so far identified
98. Promotion as a factor in carcinogenesis
99. Carcinogenicity evaluations and ongoing studies: the IARC databases
100. Working group on mechanisms of carcinogenesis and the evaluation of carcinogenic risks (meeting report)
101. Identification of carcinogens within the IARC monograph program
102. Mitogenesis is only one factor in carcinogenesis
103. Toxicity, cell proliferation, and carcinogenesis
104. Response of experimental animals to human carcinogens: an analysis based upon the IARC monographs programme
105. Multistage carcinogenesis: implication for risk evaluation
106. Salmonella mutagenicity tests: V. Results from the testing of 311 chemicals
107. Cell proliferation in experimental carcinogenesis